Effect of a New Formulation of Torasemide (Prolonged Release)on Myocardial Fibrosis in Patients With Heart Failure.

NCT00409942 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

142

Enrollment

INDUSTRY

Sponsor class

Conditions

Congestive Heart Failure

Interventions

DRUG: Torasemide Prolonged Release
DRUG: Furosemide

Sponsor

Ferrer Internacional S.A.